Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network.
about
The national drug abuse treatment clinical trials network data share project: website design, usage, challenges, and future directionsAdvances in opioid antagonist treatment for opioid addiction.Using electronic health records data to assess comorbidities of substance use and psychiatric diagnoses and treatment settings among adults.Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: a latent class analysis.Transitions in illicit drug use status over 3 years: a prospective analysis of a general population sampleEvaluating brief screeners to discriminate between drug use disorders in a sample of treatment-seeking adults.Comorbid substance use disorders with other Axis I and II mental disorders among treatment-seeking Asian Americans, Native Hawaiians/Pacific Islanders, and mixed-race people.Social Network Strategies to Address HIV Prevention and Treatment Continuum of Care Among At-risk and HIV-infected Substance Users: A Systematic Scoping Review.Drug use and phylogenetic clustering of hepatitis C virus infection among people who use drugs in Vancouver, Canada: A latent class analysis approach.Latent classes of polydrug and polyroute use and associations with human immunodeficiency virus risk behaviours and overdose among people who inject drugs in Tijuana, Baja California, Mexico.Association between severity of illicit drug dependence and quality of life in a psychosocial care center in BRAZIL: cross-sectional study.Poly-drug and marijuana use among adults who primarily used methamphetamine.Clinical characteristics of poly-drug abuse among heroin dependents and association with other psychopathology in compulsory isolation treatment settings in China.Alcohol use disorders are associated with increased HIV risk behaviors in cocaine-dependent methadone patients.
P2860
Q28658616-A8B44B54-4239-4D57-9D9D-C05E836810E2Q34262649-EB6DD71A-30E9-4954-8D7F-C8F1419F9A7FQ34556368-54D9D29C-9CBA-4124-93F6-49EE8ACE76FDQ35166932-EB0B18CB-8E37-4854-AF86-F9F5AEF4EFB5Q36384293-1EBC62CC-1F20-405A-AD44-B58840DF4984Q36418473-8E7D32B2-2990-45F2-BD84-7A9DB18FF7D6Q37355406-58F8FAA9-2D80-4931-98A0-1A1916635EB9Q38820080-E8A347E4-E3DA-429A-9B0D-40A0F026F328Q40118634-04116CC8-9E24-4483-B4CA-702857971859Q40276241-95614B45-27CB-4807-8371-7B9949AB2FFAQ43946657-72996146-7704-4DC8-BD4A-3FDB4E935649Q44164010-36170572-47DB-4D88-A18F-1F0F8DEE91F4Q47597971-652B93DE-1206-429A-B383-A51DB42B30D2Q50056142-D87A4438-F275-4741-93ED-725DCEB4CCAF
P2860
Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of item response theory an ...... n the Clinical Trials Network.
@ast
Use of item response theory an ...... n the Clinical Trials Network.
@en
type
label
Use of item response theory an ...... n the Clinical Trials Network.
@ast
Use of item response theory an ...... n the Clinical Trials Network.
@en
prefLabel
Use of item response theory an ...... n the Clinical Trials Network.
@ast
Use of item response theory an ...... n the Clinical Trials Network.
@en
P2093
P2860
P1476
Use of item response theory an ...... in the Clinical Trials Network
@en
P2093
Bruce Burchett
Bryce B Reeve
Chongming Yang
Dan G Blazer
George E Woody
Jeng-Jong Pan
Walter Ling
P2860
P304
P356
10.1016/J.DRUGALCDEP.2011.03.018
P50
P577
2011-04-17T00:00:00Z